Home/Filings/4/0001493152-23-004168
4//SEC Filing

DelAversano Robert J 4

Accession 0001493152-23-004168

CIK 0001444307other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 8:11 PM ET

Size

5.1 KB

Accession

0001493152-23-004168

Insider Transaction Report

Form 4
Period: 2023-02-09
DelAversano Robert J
Principal Accounting Officer
Transactions
  • Sale

    Common Stock

    2023-02-09$1.37/sh40$551,008 total
Footnotes (2)
  • [F1]In connection with the vesting of 49 RSUs on February 1, 2023, a total of 40 shares were sold in order to satisfy the reporting person's tax withholding obligations. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
  • [F2]Effective as of 12:01 a.m. Eastern Time on November 9, 2022, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-22.

Documents

1 file

Issuer

ONCOSEC MEDICAL Inc

CIK 0001444307

Entity typeother

Related Parties

1
  • filerCIK 0001728262

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 8:11 PM ET
Size
5.1 KB